Main Article Content
Malaria is a life threatening infectious disease causes by Plasmodium species, wherein Plasmodium falciparum being the most lethal causes severe malaria [1,2]. Plasmodium parasites have a complex life cycle and employed several immunity evading mechanism that enable the parasite to multiply and survive avoiding the host immunity . Alternative pathway and multiple proteins are available to achieve similar function if any pathway got blocked which makes vaccine development a difficult task . The rise in drug-resistant Plasmodium parasites and the unavailability of an effective vaccine lead to major challenges in controlling the parasite. Drug resistance has been also reported towards Artemisinin combination therapies (ACTs), which is the most accepted and recommended therapy, giving a major impact to the human health . And RTS,S/AS01, which is the only accepted vaccine, has low efficacy and doesn’t provide full protection . Therefore, it is of utmost important to identify novel potential targets that can be directed for therapeutic intervention . The present study hypothesized highly conserved protein, PRE-binding protein (PREBP), as a potential vaccine candidate for malaria vaccine development. PREBP is an exposed surface protein with high antigenic property and conservancy among other species of the parasite. In the present study, conservancy, localisation and the antigenicity of PREBP was determined by using different bioinformatics tools. And the 3D structure of PREBP (Figure1) was modelled using Robetta tool  and the quality of the generated model was further validated by generating Ramachandran plot . Conformational B cell epitopes of the protein were predicted using Ellipro . The generated 3-D structure of the protein can be further used for other structural analysis and docking studies. And the resulted epitopes might be of great importance as a vaccine subunit in the development of an effective malaria vaccine.
How to Cite
PREBP, vaccine, epitopes, Plasmodium falciparum, malaria
 Artavanis-Tsakonas K, Tongren JE, Riley EM. The war between the malaria parasite and the immune system: Immunity, immunoregulation and immunopathology. Clin Exp Immunol 2003;133:145–52. doi:10.1046/j.1365-2249.2003.02174.x.
 Hafalla JC, Silvie O, Matuschewski K. Cell biology and immunology of malaria. Immunol Rev 2011;240:297–316. doi:10.1111/j.1600-065X.2010.00988.x.
 Kinyanjui SM. The immunology of Malaria. Malar. Parasites, 2012, p. 175–200.
 Mokgethi-Morule T, N’Da DD. Cell based assays for anti-Plasmodium activity evaluation. Eur J Pharm Sci 2016;84:26–36. doi:10.1016/j.ejps.2016.01.001.
 Mahmoudi S, Keshavarz H. Efficacy of phase 3 trial of RTS,S/AS01 malaria vaccine : The need for an alternative development plan. Hum Vaccine Immunother 2017;13:2098–101.
 Kaur K, Jain M, Kaur T, Jain R. Antimalarials from nature. Bioorganic Med Chem 2009;17:3229–56. doi:10.1016/j.bmc.2009.02.050.
 Kim DE, Chivian D, Baker D. Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res 2004;32:W526–31. doi:10.1093/nar/gkh468.
 Ponomarenko J, Bui H-H, Li W, Fusseder N, Bourne PE, Sette A, et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics 2008;9:514. doi:10.1186/1471-2105-9-514.